The Swedish MS registry – clinical support tool and scientific resource

The Swedish MS registry (SMSreg) is designed to assure quality health care for patients with multiple sclerosis (MS). It has been active since 2001 and web‐based since 2004. It runs on government funding only and is used in all Swedish neurology departments. The SMSreg currently includes data on 14,500 of Sweden's estimated 17,500 prevalent patients with MS. One important function of SMSreg, to which participation is voluntary, is to serve as a tool for decision support and to provide an easy overview of the patient information needed at clinical visits. This is its core feature and explains why the majority of Swedish MS specialists contribute data. Another success factor for SMSreg is that entered data can be readily accessed, either through a query function into Excel format or through a set of predesigned tables and diagrams in which parameters can be selected. Recent development includes a portal allowing patients to view a summary of their registered data and to report a set of patient‐reported outcomes. SMSreg data have been used in close to 100 published scientific reports. Current projects include an incidence cohort (EIMS), post‐marketing cohorts of patients on novel disease‐modifying drugs (IMSE), and a prevalence cohort (GEMS). As these studies combine physical sampling and questionnaire data with clinical documentation and possible linkage to other public registries, together they provide an excellent platform for integrated MS research.

[1]  T. Olsson,et al.  Smokers run increased risk of developing anti-natalizumab antibodies , 2014, Multiple sclerosis.

[2]  M. Pirinen,et al.  Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis , 2013, Nature Genetics.

[3]  Jan Hillert,et al.  Human Leukocyte Antigen Genes and Interferon Beta Preparations Influence Risk of Developing Neutralizing Anti-Drug Antibodies in Multiple Sclerosis , 2014, PloS one.

[4]  T. Olsson,et al.  Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis. , 2011, Brain : a journal of neurology.

[5]  Simon C. Potter,et al.  Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis , 2011, Nature.

[6]  M. Grotle,et al.  Comparison of the SF6D, the EQ5D, and the oswestry disability index in patients with chronic low back pain and degenerative disc disease , 2013, BMC Musculoskeletal Disorders.

[7]  O. Nerman,et al.  Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs , 2013, Multiple sclerosis.

[8]  B. Lie,et al.  Oligoclonal band phenotypes in MS differ in their HLA class II association, while specific KIR ligands at HLA class I show association to MS in general , 2014, Journal of Neuroimmunology.

[9]  T. Olsson,et al.  Reverse causality behind the association between reproductive history and MS , 2014, Multiple sclerosis.

[10]  Eric Westman,et al.  Multiple sclerosis patients lacking oligoclonal bands in the cerebrospinal fluid have less global and regional brain atrophy , 2014, Journal of Neuroimmunology.

[11]  O. Andersen,et al.  Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. , 1993, Brain : a journal of neurology.

[12]  T. Olsson,et al.  Sunlight is associated with decreased multiple sclerosis risk: no interaction with human leukocyte antigen‐DRB1*15 , 2012, European journal of neurology.

[13]  T. Olsson,et al.  Alcohol as a modifiable lifestyle factor affecting multiple sclerosis risk. , 2014, JAMA neurology.

[14]  M. Bottai,et al.  Modest familial risks for multiple sclerosis: a registry-based study of the population of Sweden , 2014, Brain : a journal of neurology.

[15]  T. Olsson,et al.  Fatty fish intake is associated with decreased occurrence of multiple sclerosis , 2014, Multiple sclerosis.

[16]  T. Olsson,et al.  Epstein-Barr virus and multiple sclerosis: interaction with HLA , 2011, Genes and Immunity.

[17]  J. Hillert,et al.  Impact of cerebrospinal-fluid oligoclonal immunoglobulin bands and HLA-DRB1 risk alleles on brain magnetic-resonance-imaging lesion load in Swedish multiple sclerosis patients , 2013, Journal of Neuroimmunology.

[18]  T. Olsson,et al.  Exposure to environmental tobacco smoke is associated with increased risk for multiple sclerosis , 2011, Multiple sclerosis.

[19]  A. Odén,et al.  High nationwide prevalence of multiple sclerosis in Sweden , 2011, Multiple sclerosis.

[20]  T. Olsson,et al.  Smoking and multiple sclerosis susceptibility , 2013, European Journal of Epidemiology.

[21]  A. Thompson,et al.  Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples , 2002, Journal of neurology, neurosurgery, and psychiatry.

[22]  Hanne F. Harbo,et al.  Oligoclonal Band Status in Scandinavian Multiple Sclerosis Patients Is Associated with Specific Genetic Risk Alleles , 2013, PloS one.

[23]  F. Piehl,et al.  Swedish natalizumab (Tysabri) multiple sclerosis surveillance study , 2010, Neurological Sciences.

[24]  O. Andersen,et al.  From the Gothenburg cohort to the Swedish multiple sclerosis registry , 2012, Acta neurologica Scandinavica. Supplementum.

[25]  T. Olsson,et al.  Smoking and risk of treatment-induced neutralizing antibodies to interferon β-1a , 2014, Multiple sclerosis.

[26]  T. Olsson,et al.  Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis , 2009, Neurology.

[27]  J. Hillert,et al.  Multiple sclerosis with and without CSF bands: Clinically indistinguishable but immunogenetically distinct , 2006, Neurology.

[28]  T. Olsson,et al.  Nicotine might have a protective effect in the etiology of multiple sclerosis , 2013, Multiple sclerosis.